Research programme: factor Xa inhibitors - Mochida

Drug Profile

Research programme: factor Xa inhibitors - Mochida

Alternative Names: M 55165; M 55529; M 55532; M 55551; M 65644

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mochida Pharmaceutical
  • Class Piperazines; Piperidines; Spiro compounds
  • Mechanism of Action Factor Xa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Thrombosis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in Japan
  • 10 Apr 2006 A preclinical study has been added to the pharmacokinetics and Thromboses pharmacodynamics sections
  • 20 Sep 2005 Data presented at the 230th American Chemical Society National Meeting (230th-ACS-2005) have been added to the adverse events, pharmacokinetics and Thromboses pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top